Keybanc analyst Brett Andress downgrades Caesars Entertainment (NASDAQ:CZR) from Overweight to Sector Weight.
Akari Therapeutics Announces Receipt Of Nasdaq Minimum Bid Price Notification
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that Akari received a letter from Nasdaq Listing